Literature DB >> 18692180

HIV-1 Tat protein induces TNF-alpha and IL-10 production by human macrophages: differential implication of PKC-betaII and -delta isozymes and MAP kinases ERK1/2 and p38.

Kaoutar Leghmari1, Xavier Contreras, Corinne Moureau, Elmostafa Bahraoui.   

Abstract

In this study, we demonstrate that HIV-1 Tat protein is able to induce IL-10 and TNF-alpha in human macrophages. We show that N-terminal Tat 1-45 fragment initiates the PKC pathway by acting at the membrane. Inhibition of PKC pathway, by chemical inhibitors or after PMA treatment, abolishes both IL-10 and TNF-alpha production. Among the eight PKC isoforms present in macrophages, we show that only PKC-betaIotaIota and -delta are activated by Tat or Tat 1-45 in human macrophages. However, their selective inhibition affects only IL-10 production. Downstream of PKC, Tat activates the MAP kinases p38 and ERK1/2 and the transcription factor NF-kappaB. Using chemical inhibitors we show that (i) both ERK1/2 MAP kinase and NF-kappaB transcription factor play an important role in IL-10 and TNF-alpha production, in macrophages stimulated by Tat. However, p38 MAP kinase seems to be involved only in IL-10 and not TNF-alpha production.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18692180     DOI: 10.1016/j.cellimm.2008.06.011

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  19 in total

Review 1.  Signaling through the P38 and ERK pathways: a common link between HIV replication and the immune response.

Authors:  Robert L Furler; Christel H Uittenbogaart
Journal:  Immunol Res       Date:  2010-12       Impact factor: 2.829

2.  Expression of human endogenous retrovirus type K (HML-2) is activated by the Tat protein of HIV-1.

Authors:  Marta J Gonzalez-Hernandez; Michael D Swanson; Rafael Contreras-Galindo; Sarah Cookinham; Steven R King; Richard J Noel; Mark H Kaplan; David M Markovitz
Journal:  J Virol       Date:  2012-05-16       Impact factor: 5.103

3.  HIV-1 Tat Protein Activates both the MyD88 and TRIF Pathways To Induce Tumor Necrosis Factor Alpha and Interleukin-10 in Human Monocytes.

Authors:  Rémi Planès; Nawal Ben Haij; Kaoutar Leghmari; Manutea Serrero; Lbachir BenMohamed; Elmostafa Bahraoui
Journal:  J Virol       Date:  2016-06-10       Impact factor: 5.103

4.  Therapeutic doses of irradiation activate viral transcription and induce apoptosis in HIV-1 infected cells.

Authors:  Sergey Iordanskiy; Rachel Van Duyne; Gavin C Sampey; Caitlin M Woodson; Kelsi Fry; Mohammed Saifuddin; Jia Guo; Yuntao Wu; Fabio Romerio; Fatah Kashanchi
Journal:  Virology       Date:  2015-07-14       Impact factor: 3.616

5.  Chronic central nervous system expression of HIV-1 Tat leads to accelerated rarefaction of neocortical capillaries and loss of red blood cell velocity heterogeneity.

Authors:  Jharon N Silva; Oksana Polesskaya; Helen S Wei; Izad-Yar D Rasheed; Jeffrey M Chamberlain; Christopher Nishimura; Changyong Feng; Stephen Dewhurst
Journal:  Microcirculation       Date:  2014-10       Impact factor: 2.628

6.  Cannabinoid inhibition of macrophage migration to the trans-activating (Tat) protein of HIV-1 is linked to the CB(2) cannabinoid receptor.

Authors:  Erinn S Raborn; Guy A Cabral
Journal:  J Pharmacol Exp Ther       Date:  2010-01-20       Impact factor: 4.030

7.  Cannabinoid inhibits HIV-1 Tat-stimulated adhesion of human monocyte-like cells to extracellular matrix proteins.

Authors:  Erinn S Raborn; Melissa Jamerson; Francine Marciano-Cabral; Guy A Cabral
Journal:  Life Sci       Date:  2014-04-15       Impact factor: 5.037

8.  Tumor necrosis factor-alpha levels in HIV-1 seropositive injecting drug users.

Authors:  Raymond L Ownby; Adarsh M Kumar; J Benny Fernandez; Irina Moleon-Borodowsky; Louis Gonzalez; Seth Eisdorfer; Drenna Waldrop-Valverde; Mahendra Kumar
Journal:  J Neuroimmune Pharmacol       Date:  2009-04-04       Impact factor: 4.147

9.  Development of a platelet-activating factor antagonist for HIV-1 associated neurocognitive disorders.

Authors:  Dawn Eggert; Prasanta K Dash; Nawal Serradji; Chang-Zhi Dong; Pascal Clayette; Francoise Heymans; Huanyu Dou; Santhi Gorantla; Harris A Gelbard; Larisa Poluektova; Howard E Gendelman
Journal:  J Neuroimmunol       Date:  2009-06-21       Impact factor: 3.478

10.  Interleukin-10 attenuates vascular responses to endothelin-1 via effects on ERK1/2-dependent pathway.

Authors:  Fernanda R C Giachini; Saiprasad M Zemse; Fernando S Carneiro; Victor V Lima; Zidonia N Carneiro; Glaucia E Callera; Adviye Ergul; R Clinton Webb; Rita C Tostes
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-12-12       Impact factor: 4.733

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.